[1]Patent:US2014/200206,2014,A1.Locationinpatent:Paragraph0230
[1]JournalofPharmacologyandExperimentalTherapeutics,2019,vol.370,p.514-527
211374-82-2
49834-28-8
878160-13-5
917909-47-8
284462-56-2
927672-81-9
871125-86-9 | 2-Piperazinopyridine-5-boronic acid, pinacol ester | AA004P3V | MFCD06795677
850349-32-5 | 4-(3-Bromo-benzenesulfonyl)-thiomorpholine | AA004PSM | MFCD06657738
848774-93-6 | (6-Methylpyridazin-3-yl)methanol | AA004QJY | MFCD08236825
847818-57-9 | 1-Propylpyrazole-4-boronic acid | AA004RER | MFCD11504862
86770-75-4 | 2-(Benzyloxyethoxyethoxy)ethylamine | AA004S8C | MFCD22383750
83277-23-0 | 2,4-Dichloro-3-methylbenzoic acid | AA004T01 | MFCD16659660
871332-84-2 | 3-(Methoxy(methyl)aminocarbonyl)-5-nitrophenylboronic acid | AA004TSL | MFCD07783876
83578-21-6 | 2-(Pyridin-2-yldisulfanyl)ethanamine | AA004UCQ | MFCD01863453
859850-75-2 | 1-Methyl-1H-indole-5-sulfonyl chloride | AA004VKU | MFCD08271907
828270-62-8 | 4-Fluoro-2-methyl-1-(methylsulfonyl)benzene | AA004WXC | MFCD04037935